These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 19147306

  • 21. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
    Guckenberger M, Meyer J, Baier K, Vordermark D, Flentje M.
    Radiat Oncol; 2006 Sep 06; 1():34. PubMed ID: 16956403
    [Abstract] [Full Text] [Related]

  • 22. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF, Das S, Temple K, Bynum S, Catalano S, Koontz JI, Montana GS, Oleson JR.
    Med Dosim; 2009 Sep 06; 34(3):256-60. PubMed ID: 19647638
    [Abstract] [Full Text] [Related]

  • 23. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
    Jensen I, Carl J, Lund B, Larsen EH, Nielsen J.
    Med Dosim; 2011 Sep 06; 36(2):130-7. PubMed ID: 20488692
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter.
    Schwarz M, Lebesque JV, Mijnheer BJ, Damen EM.
    Radiother Oncol; 2004 Nov 06; 73(2):209-18. PubMed ID: 15542168
    [Abstract] [Full Text] [Related]

  • 25. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T, Fiorino C, Gagliardi G, Cattaneo GM, Sanguineti G, Borca VC, Cozzarini C, Fellin G, Foppiano F, Girelli G, Menegotti L, Piazzolla A, Vavassori V, Valdagni R.
    Radiother Oncol; 2004 Oct 06; 73(1):21-32. PubMed ID: 15465142
    [Abstract] [Full Text] [Related]

  • 26. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
    van der Laan HP, van den Bergh A, Schilstra C, Vlasman R, Meertens H, Langendijk JA.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1138-45. PubMed ID: 17931794
    [Abstract] [Full Text] [Related]

  • 27. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A, Töws N, Schmidberger H, Hess CF.
    Strahlenther Onkol; 2005 Dec 15; 181(12):789-95. PubMed ID: 16362789
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial.
    Koper PC, Jansen P, van Putten W, van Os M, Wijnmaalen AJ, Lebesque JV, Levendag PC.
    Radiother Oncol; 2004 Oct 15; 73(1):1-9. PubMed ID: 15465140
    [Abstract] [Full Text] [Related]

  • 30. Treatment margins and treatment fractionation in conformal radiotherapy of muscle-invading urinary bladder cancer.
    Muren LP, Redpath AT, McLaren DB.
    Radiother Oncol; 2004 Apr 15; 71(1):65-71. PubMed ID: 15066297
    [Abstract] [Full Text] [Related]

  • 31. Low-grade toxicity after conformal radiation therapy for prostate cancer--impact of bladder volume.
    Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Eble MJ.
    Int J Radiat Oncol Biol Phys; 2006 Mar 01; 64(3):835-41. PubMed ID: 16289911
    [Abstract] [Full Text] [Related]

  • 32. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS, Tomé WA, Jaradat H, Raisbeck BM, Ritter MA.
    Acta Oncol; 2006 Mar 01; 45(6):717-27. PubMed ID: 16938815
    [Abstract] [Full Text] [Related]

  • 33. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Konishi K, Yoshioka Y, Isohashi F, Sumida I, Kawaguchi Y, Kotsuma T, Adachi K, Morimoto M, Fukuda S, Inoue T.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1003-7. PubMed ID: 19345517
    [Abstract] [Full Text] [Related]

  • 34. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach M.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):654-62. PubMed ID: 17011444
    [Abstract] [Full Text] [Related]

  • 35. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
    Peeters ST, Lebesque JV, Heemsbergen WD, van Putten WL, Slot A, Dielwart MF, Koper PC.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1151-61. PubMed ID: 16414208
    [Abstract] [Full Text] [Related]

  • 36. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
    Fiorino C, Fellin G, Rancati T, Vavassori V, Bianchi C, Borca VC, Girelli G, Mapelli M, Menegotti L, Nava S, Valdagni R.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1130-7. PubMed ID: 17881142
    [Abstract] [Full Text] [Related]

  • 37. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1124-9. PubMed ID: 18313526
    [Abstract] [Full Text] [Related]

  • 38. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer.
    Cheung R, Tucker SL, Ye JS, Dong L, Liu H, Huang E, Mohan R, Kuban D.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1513-9. PubMed ID: 15050331
    [Abstract] [Full Text] [Related]

  • 39. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?
    Sanguineti G, Cavey ML, Endres EJ, Brandon GG, Bayouth JE.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):151-60. PubMed ID: 16198066
    [Abstract] [Full Text] [Related]

  • 40. Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy.
    Jereczek-Fossa BA, Zerini D, Fodor C, Santoro L, Serafini F, Cambria R, Vavassori A, Cattani F, Garibaldi C, Gherardi F, Ferrari A, Rocco B, Scardino E, de Cobelli O, Orecchia R.
    Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):26-34. PubMed ID: 20133085
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.